Nogueira C R, Leite C C, Chedid E P, Liberman B, Pimentel-Filho F R, Kopp P, Medeiros-Neto G A
Department of Internal Medicine, University of Sao Paulo Medical School, Brazil.
J Endocrinol Invest. 1997 Nov;20(10):629-33. doi: 10.1007/BF03346922.
Familial hypopituitarism represents a clinically and genetically heterogeneous disorder. In a subset of these families, defects in Pit-I, a transcription factor essential for proper pituitary development have been identified as underlying molecular cause. These patients present extreme short stature, GH, PRL and TSH deficiency but intact ACTH, LH and FSH secretion. The pituitary is usually hypoplastic. In this report we describe a consanguineous family (the parents are first cousins) with thirteen siblings. Of the ten living siblings, four (two males and two females) have panhypopituitarism with severe growth failure. They had evidence of growth hormone, prolactin and gonadotropin deficiencies and developed central hypothyroidism late in life. ACTH secretion was normal. Bone age was retarded and dual-photon bone densitometry indicated severe osteoporosis. Combined provocative tests for pituitary hormones indicated blunted responses for GH, LH, FSH and a modest rise in serum PRL and TSH. A clonidine-test failed to induce pituitary GH response. A corticotropin-releasing factor (CRF) provocative test was conducted after 6 months without the use of prednisone with a normal ACTH response after CRF in the affected sibling. Plasma IGF-I and IGF-BP3 were below normal levels. Serum E2 (females) and serum testosterone (males) levels were very low. MRI evaluation of the pituitary indicated pituitary aplasia in all subjects. The phenotype described in this kindred is different from families reported with Pit-1 mutations. However, it resembles previously published kindreds with similar clinical and biochemical findings. The relative preservation of ACTH suggests a genetic defect early in pituitary gland development.
家族性垂体功能减退症是一种临床和遗传异质性疾病。在这些家族的一个亚组中,已确定垂体发育正常所必需的转录因子Pit-1缺陷是潜在的分子病因。这些患者表现为极度身材矮小、生长激素(GH)、催乳素(PRL)和促甲状腺激素(TSH)缺乏,但促肾上腺皮质激素(ACTH)、促黄体生成素(LH)和促卵泡生成素(FSH)分泌正常。垂体通常发育不全。在本报告中,我们描述了一个有13个兄弟姐妹的近亲家族(父母是表亲)。在10个在世的兄弟姐妹中,有4个(2名男性和2名女性)患有全垂体功能减退症并伴有严重生长发育迟缓。他们有生长激素、催乳素和促性腺激素缺乏的证据,并在晚年出现中枢性甲状腺功能减退。ACTH分泌正常。骨龄延迟,双能X线骨密度测定显示严重骨质疏松。垂体激素联合激发试验表明,GH、LH、FSH反应迟钝,血清PRL和TSH有适度升高。可乐定试验未能诱导垂体GH反应。在未使用泼尼松6个月后,对一名患病兄弟姐妹进行促肾上腺皮质激素释放因子(CRF)激发试验,CRF后ACTH反应正常。血浆胰岛素样生长因子-I(IGF-I)和胰岛素样生长因子结合蛋白-3(IGF-BP3)低于正常水平。女性血清雌二醇(E2)和男性血清睾酮水平非常低。垂体的MRI评估显示所有受试者垂体发育不全。这个家族中描述的表型与报道有Pit-1突变的家族不同。然而,它与先前发表的具有相似临床和生化发现的家族相似。ACTH的相对保留提示垂体发育早期存在遗传缺陷。